bleedingjobs.blogspot.com — GlaxoSmithKline plans to close Dartford, UK manufacturing plant, cutting 620 more jobs by 2013. The cuts come as CEO Andrew Witty attempts to improve returns for shareholders, while patents expire and sales drop for brand-name products like Valtrex.